Market Overview:
The global dopamine hydrochloride injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of Parkinson’s disease, rising demand for better treatment options, and growing awareness about dopamine hydrochloride injection. Based on type, the global dopamine hydrochloride injection market is segmented into 200mg/250ml, 400mg/250ml, and 800mg/250ml segments. The 400mg/250ml segment is expected to account for the largest share of the global dopamine hydrochloride injection market in 2018. This segment is also projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. Based on application, the global dopamine hydrochloride injection market is divided into hospital, clinics, and recovery center segments.
Product Definition:
A dopamine hydrochloride injection is a medication that is used to treat low blood pressure, shock, and heart attack.
200mg/250ml:
200mg/250ml is a generic name for dobutamine hydrochloride injection. It contains 200 mg of dobutamine hydrochloride and 250 milliliters of saline solution. Dopamine is used to treat heart failure, which is a situation where the body’s pumping ability to get blood to the heart muscle gets reduced because of some reason or another.
400mg/250ml:
400mg/250ml is a generic medicine used for the treatment of Parkinson's disease. It is also used as an off-label drug to treat symptoms of Alzheimer’s, such as dementia and cognitive impairment. 400 mg/ 250 ml Dopamine Hydrochloride injection contains 400 mg of Dopamine Hydrochloride and 250 m lof water for injection purposes.
Application Insights:
The hospital application segment dominated the global market in 2017. The recovery center is a new addition to the hospital and clinics applications. These centers provide treatment for patients suffering from Parkinson¢â‚¬â„¢s disease, which requires regular injections of dopamine hydrochloride. Increasing awareness about these centers and growing patient acceptance are expected to drive growth over the forecast period.
Clinics have been witnessing an increasing number of patients suffering from depression due to loss of employment or relationship breakups as well as an increase in stress levels owing to exams or job interviews etc., Thus, it has been observed that majority of these patients suffer from anxiety disorders too which require treatment with antidepressants along with PD medication thus leading to high demand for such injections at low cost at clinics thereby driving its usage rate among other applications across regions globally.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, availability of technologically advanced products and high prevalence of substance use disorders are some factors attributing to its large share. Moreover, increasing number of R&D activities by major companies is one factor expected to drive the region’s growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as India and China. Furthermore, growing medical tourism industry due to low cost treatment options offered by these countries will also boost market development during the projected time frame. ‰ ‘‘” ‘’” â–¬—'12; 15(4): p.; 8 ref.; 1 fig.
Growth Factors:
- Increasing demand for dopamine hydrochloride injection from the pharmaceutical and biotechnology industries for research and development purposes.
- Rising prevalence of neurological disorders such as Parkinson's disease, attention-deficit hyperactivity disorder (ADHD), and depression is expected to drive the demand for dopamine hydrochloride injection over the forecast period.
- Growing awareness about the benefits of dopamine hydrochloride injection in treating various neurological disorders is projected to boost its demand in coming years.
- Technological advancements in manufacturing processes are likely to result in reduced production costs of dopamine hydrochloride injection, which is expected to fuel its market growth over the forecast period. 5) The increasing use of dopaminergic drugs for treating Parkinson's disease is anticipated to create lucrative opportunities for dopamine hydrochloride injection market during the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Dopamine Hydrochloride Injection Market Research Report
By Type
200mg/250ml, 400mg/250ml, 800mg/250ml
By Application
Hospital, Clinics, Recovery Center
By Companies
Pfizer, American Regent, Baxter, Smarth Life Sciences, Hikma, SG Pharma, Shanghai Harvest Pharmaceutical, Wuhan Jiuan Pharmaceutical, Grand Pharma, Yabang Pharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global Dopamine Hydrochloride Injection Market Report Segments:
The global Dopamine Hydrochloride Injection market is segmented on the basis of:
Types
200mg/250ml, 400mg/250ml, 800mg/250ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- American Regent
- Baxter
- Smarth Life Sciences
- Hikma
- SG Pharma
- Shanghai Harvest Pharmaceutical
- Wuhan Jiuan Pharmaceutical
- Grand Pharma
- Yabang Pharm
Highlights of The Dopamine Hydrochloride Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 200mg/250ml
- 400mg/250ml
- 800mg/250ml
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dopamine Hydrochloride Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dopamine hydrochloride injection is a medication used to treat Parkinson's disease. It is a dopamine agonist, which means it helps increase the amount of dopamine in the brain.
Some of the major companies in the dopamine hydrochloride injection market are Pfizer, American Regent, Baxter, Smarth Life Sciences, Hikma, SG Pharma, Shanghai Harvest Pharmaceutical, Wuhan Jiuan Pharmaceutical, Grand Pharma, Yabang Pharm.
The dopamine hydrochloride injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dopamine Hydrochloride Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dopamine Hydrochloride Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dopamine Hydrochloride Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dopamine Hydrochloride Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dopamine Hydrochloride Injection Market Size & Forecast, 2020-2028
4.5.1 Dopamine Hydrochloride Injection Market Size and Y-o-Y Growth
4.5.2 Dopamine Hydrochloride Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 200mg/250ml
5.2.2 400mg/250ml
5.2.3 800mg/250ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dopamine Hydrochloride Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dopamine Hydrochloride Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 200mg/250ml
9.6.2 400mg/250ml
9.6.3 800mg/250ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 200mg/250ml
10.6.2 400mg/250ml
10.6.3 800mg/250ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 200mg/250ml
11.6.2 400mg/250ml
11.6.3 800mg/250ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 200mg/250ml
12.6.2 400mg/250ml
12.6.3 800mg/250ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 200mg/250ml
13.6.2 400mg/250ml
13.6.3 800mg/250ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dopamine Hydrochloride Injection Market: Competitive Dashboard
14.2 Global Dopamine Hydrochloride Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 American Regent
14.3.3 Baxter
14.3.4 Smarth Life Sciences
14.3.5 Hikma
14.3.6 SG Pharma
14.3.7 Shanghai Harvest Pharmaceutical
14.3.8 Wuhan Jiuan Pharmaceutical
14.3.9 Grand Pharma
14.3.10 Yabang Pharm
